Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
POLR3B - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 971 | 680 |
|
PreventionGenetics, part of Exact Sciences United States | 285 | 137 |
|
Invitae Hypogonadotropic Hypogonadism Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 67 | 46 |
|
PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Leukodystrophy and Leukoencephalopathy, Adult Onset Panel PreventionGenetics, part of Exact Sciences United States | 67 | 45 |
|
Leukodystrophy and Leukoencephalopathy Panel PreventionGenetics, part of Exact Sciences United States | 202 | 212 |
|
Comprehensive Neuropathy Panel PreventionGenetics, part of Exact Sciences United States | 209 | 145 |
|
Leukodystrophy and leukoencephalopathy panel. NGS panel of 74 genes. Genologica Medica Spain | 96 | 74 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Leukodystrophy, hypomyelinating: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 18 | 18 |
|
Kallmann Syndrome & Hypogonadotropic Hypogonadism NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 34 | 39 |
|
Fulgent Genetics United States | 505 | 132 |
|
Hypomyelinating Leukodystrophy NGS Panel Fulgent Genetics United States | 225 | 62 |
|
Fulgent Genetics United States | 533 | 149 |
|
Hypomyelination - hypogonadotropic hypogonadism - hypodontia Bioarray Spain | 1 | 1 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.